| Year |
Citation |
Score |
| 2014 |
Maximova OA, Speicher JM, Skinner JR, Murphy BR, St Claire MC, Ragland DR, Herbert RL, Pare DR, Moore RM, Pletnev AG. Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine. Vaccine. 32: 3187-97. PMID 24736001 DOI: 10.1016/j.vaccine.2014.04.002 |
0.406 |
|
| 2011 |
Durbin AP, Whitehead SS, Shaffer D, Elwood D, Wanionek K, Thumar B, Blaney JE, Murphy BR, Schmidt AC. A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial. Plos Neglected Tropical Diseases. 5: e1267. PMID 21829748 DOI: 10.1371/journal.pntd.0001267 |
0.355 |
|
| 2011 |
Karron RA, Casey R, Thumar B, Surman S, Murphy BR, Collins PL, Schmidt AC. The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children. The Pediatric Infectious Disease Journal. 30: e186-91. PMID 21829138 DOI: 10.1097/INF.0b013e31822ea24f |
0.336 |
|
| 2011 |
Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annual Review of Immunology. 29: 587-619. PMID 21219187 DOI: 10.1146/annurev-immunol-031210-101315 |
0.317 |
|
| 2011 |
Durbin AP, Schmidt A, Elwood D, Wanionek KA, Lovchik J, Thumar B, Murphy BR, Whitehead SS. Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic. The Journal of Infectious Diseases. 203: 327-34. PMID 21208923 DOI: 10.1093/infdis/jiq059 |
0.357 |
|
| 2010 |
DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine. 29: 17-25. PMID 21034822 DOI: 10.1016/J.Vaccine.2010.10.024 |
0.35 |
|
| 2010 |
Maximova OA, Murphy BR, Pletnev AG. High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence. Vaccine. 28: 8315-26. PMID 20688036 DOI: 10.1016/j.vaccine.2010.07.070 |
0.302 |
|
| 2010 |
Engel AR, Rumyantsev AA, Maximova OA, Speicher JM, Heiss B, Murphy BR, Pletnev AG. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome. Virology. 405: 243-52. PMID 20594569 DOI: 10.1016/j.virol.2010.06.014 |
0.353 |
|
| 2010 |
Schaap-Nutt A, Scull MA, Schmidt AC, Murphy BR, Pickles RJ. Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys. Vaccine. 28: 2788-98. PMID 20139039 DOI: 10.1016/J.Vaccine.2010.01.050 |
0.355 |
|
| 2010 |
Bukreyev AA, Dinapoli JM, Yang L, Murphy BR, Collins PL. Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic. Virology. 399: 290-8. PMID 20129638 DOI: 10.1016/j.virol.2010.01.015 |
0.361 |
|
| 2010 |
DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. Journal of Virology. 84: 1489-503. PMID 19923177 DOI: 10.1128/Jvi.01946-09 |
0.382 |
|
| 2010 |
Blaney JE, Durbin AP, Murphy BR, Whitehead SS. Targeted mutagenesis as a rational approach to dengue virus vaccine development. Current Topics in Microbiology and Immunology. 338: 145-58. PMID 19802584 DOI: 10.1007/978-3-642-02215-9_11 |
0.327 |
|
| 2009 |
Wright PF, Durbin AP, Whitehead SS, Ikizler MR, Henderson S, Blaney JE, Thumar B, Ankrah S, Rock MT, McKinney BA, Murphy BR, Schmidt AC. Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. The American Journal of Tropical Medicine and Hygiene. 81: 834-41. PMID 19861619 DOI: 10.4269/Ajtmh.2009.09-0131 |
0.665 |
|
| 2009 |
Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 27: 4953-60. PMID 19540952 DOI: 10.1016/J.Vaccine.2009.05.099 |
0.348 |
|
| 2009 |
Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine. 27: 3744-53. PMID 19464558 DOI: 10.1016/j.vaccine.2009.03.082 |
0.361 |
|
| 2009 |
Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. The Journal of Infectious Diseases. 199: 711-6. PMID 19210163 DOI: 10.1086/596558 |
0.346 |
|
| 2009 |
DiNapoli JM, Ward JM, Cheng L, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine. 27: 1530-9. PMID 19168110 DOI: 10.1016/J.Vaccine.2009.01.009 |
0.369 |
|
| 2008 |
McArthur JH, Durbin AP, Marron JA, Wanionek KA, Thumar B, Pierro DJ, Schmidt AC, Blaney JE, Murphy BR, Whitehead SS. Phase I clinical evaluation of rDEN4Δ30-200,201: A live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity American Journal of Tropical Medicine and Hygiene. 79: 678-684. PMID 18981503 |
0.402 |
|
| 2008 |
Collins PL, Bukreyev A, Murphy BR. What are the risks - hypothetical and observed - of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses? Journal of Virology. 82: 9805-9806. PMID 18796655 DOI: 10.1128/Jvi.01336-08 |
0.4 |
|
| 2008 |
Yang L, Sanchez A, Ward JM, Murphy BR, Collins PL, Bukreyev A. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals Virology. 377: 255-264. PMID 18570964 DOI: 10.1016/J.Virol.2008.04.029 |
0.343 |
|
| 2008 |
Maximova OA, Ward JM, Asher DM, St Claire M, Finneyfrock BW, Speicher JM, Murphy BR, Pletnev AG. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. Journal of Virology. 82: 5255-68. PMID 18353947 DOI: 10.1128/JVI.00172-08 |
0.36 |
|
| 2008 |
Wright PF, Ankrah S, Henderson SE, Durbin AP, Speicher J, Whitehead SS, Murphy BR, Pletnev AG. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. Vaccine. 26: 882-90. PMID 18207289 DOI: 10.1016/j.vaccine.2007.12.015 |
0.401 |
|
| 2008 |
Blaney JE, Sathe NS, Goddard L, Hanson CT, Romero TA, Hanley KA, Murphy BR, Whitehead SS. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4. Vaccine. 26: 817-28. PMID 18191005 DOI: 10.1016/J.Vaccine.2007.11.082 |
0.367 |
|
| 2007 |
Jin H, Manetz S, Leininger J, Luke C, Subbarao K, Murphy B, Kemble G, Coelingh KL. Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets Vaccine. 25: 8664-8672. PMID 18031873 DOI: 10.1016/J.Vaccine.2007.10.032 |
0.465 |
|
| 2007 |
Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, O'Shea AF, Gruber WC, Murphy BR. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine. 25: 7372-8. PMID 17868959 DOI: 10.1016/j.vaccine.2007.08.014 |
0.379 |
|
| 2007 |
DiNapoli JM, Yang L, Suguitan A, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. Journal of Virology. 81: 11560-8. PMID 17715243 DOI: 10.1128/Jvi.00713-07 |
0.361 |
|
| 2007 |
Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nature Reviews. Microbiology. 5: 518-28. PMID 17558424 DOI: 10.1038/nrmicro1690 |
0.378 |
|
| 2007 |
DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proceedings of the National Academy of Sciences of the United States of America. 104: 9788-93. PMID 17535926 DOI: 10.1073/Pnas.0703584104 |
0.373 |
|
| 2007 |
Blaney JE, Sathe NS, Hanson CT, Firestone CY, Murphy BR, Whitehead SS. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1. Virology Journal. 4: 23. PMID 17328799 DOI: 10.1186/1743-422X-4-23 |
0.304 |
|
| 2007 |
Surman SR, Collins PL, Murphy BR, Skiadopoulos MH. An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials Journal of Virological Methods. 141: 30-33. PMID 17210187 DOI: 10.1016/j.jviromet.2006.11.024 |
0.349 |
|
| 2006 |
Buchholz UJ, Nagashima K, Murphy BR, Collins PL. Live vaccines for human metapneumovirus designed by reverse genetics Expert Review of Vaccines. 5: 695-706. PMID 17181442 DOI: 10.1586/14760584.5.5.695 |
0.394 |
|
| 2006 |
Durbin AP, McArthur JH, Marron JA, Blaney JE, Thumar B, Wanionek K, Murphy BR, Whitehead SS. rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults. Human Vaccines. 2: 255-60. PMID 17106267 |
0.398 |
|
| 2006 |
Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL. Nonsegmented negative-strand viruses as vaccine vectors Journal of Virology. 80: 10293-10306. PMID 17041210 DOI: 10.1128/Jvi.00919-06 |
0.307 |
|
| 2006 |
Durbin AP, McArthur J, Marron JA, Blaney JE, Thumar B, Wanionek K, Murphy BR, Whitehead SS. The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers. Human Vaccines. 2: 167-73. PMID 17012875 |
0.395 |
|
| 2006 |
Suguitan AL, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. Plos Medicine. 3: e360. PMID 16968127 DOI: 10.1371/Journal.Pmed.0030360 |
0.436 |
|
| 2006 |
Pletnev AG, Swayne DE, Speicher J, Rumyantsev AA, Murphy BR. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine. 24: 6392-404. PMID 16831498 DOI: 10.1016/j.vaccine.2006.06.008 |
0.373 |
|
| 2006 |
Blaney JE, Durbin AP, Murphy BR, Whitehead SS. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunology. 19: 10-32. PMID 16553547 DOI: 10.1089/vim.2006.19.10 |
0.405 |
|
| 2006 |
Bukreyev A, Yang L, Zaki SR, Shieh WJ, Rollin PE, Murphy BR, Collins PL, Sanchez A. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. Journal of Virology. 80: 2267-79. PMID 16474134 DOI: 10.1128/Jvi.80.5.2267-2279.2006 |
0.354 |
|
| 2006 |
Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. The Journal of Infectious Diseases. 193: 573-81. PMID 16425137 DOI: 10.1086/499600 |
0.36 |
|
| 2006 |
Subbarao K, Murphy BR, Fauci AS. Development of effective vaccines against pandemic influenza. Immunity. 24: 5-9. PMID 16413916 DOI: 10.1016/j.immuni.2005.12.005 |
0.359 |
|
| 2006 |
Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly AM, Gruber WC, Bernstein DI, Wright PF. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 24: 2432-9. PMID 16406170 DOI: 10.1016/j.vaccine.2005.12.002 |
0.315 |
|
| 2006 |
Rumyantsev AA, Chanock RM, Murphy BR, Pletnev AG. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine. 24: 133-43. PMID 16115704 DOI: 10.1016/J.Vaccine.2005.07.067 |
0.553 |
|
| 2005 |
Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. Journal of Virology. 79: 13275-84. PMID 16227250 DOI: 10.1128/Jvi.79.21.13275-13284.2005 |
0.343 |
|
| 2005 |
Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates Journal of Virology. 79: 12608-12613. PMID 16160190 DOI: 10.1128/JVI.79.19.12608-12613.2005 |
0.331 |
|
| 2005 |
Collins PL, Murphy BR. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics Proceedings of the American Thoracic Society. 2: 166-173. PMID 16113487 DOI: 10.1513/pats.200501-011AW |
0.357 |
|
| 2005 |
Stadler K, Roberts A, Becker S, Vogel L, Eickmann M, Kolesnikova L, Klenk HD, Murphy B, Rappuoli R, Abrignani S, Subbarao K. SARS vaccine protective in mice. Emerging Infectious Diseases. 11: 1312-1314. PMID 16110580 DOI: 10.3201/Eid1108.041003 |
0.495 |
|
| 2005 |
Kapikian AZ, Simonsen L, Vesikari T, Hoshino Y, Morens DM, Chanock RM, La Montagne JR, Murphy BR. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. The Journal of Infectious Diseases. 192: S22-9. PMID 16088801 DOI: 10.1086/431510 |
0.507 |
|
| 2005 |
Bartlett EJ, Amaro-Carambot E, Surman SR, Newman JT, Collins PL, Murphy BR, Skiadopoulos MH. Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys Vaccine. 23: 4631-4646. PMID 15951066 DOI: 10.1016/j.vaccine.2005.04.035 |
0.359 |
|
| 2005 |
Blaney JE, Matro JM, Murphy BR, Whitehead SS. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. Journal of Virology. 79: 5516-28. PMID 15827166 DOI: 10.1128/JVI.79.9.5516-5528.2005 |
0.376 |
|
| 2005 |
Hanley KA, Goddard LB, Gilmore LE, Scott TW, Speicher J, Murphy BR, Pletnev AG. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors Vector-Borne and Zoonotic Diseases. 5: 1-10. PMID 15815144 DOI: 10.1089/Vbz.2005.5.1 |
0.357 |
|
| 2005 |
Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, Gruber W, Murphy BR, Collins PL. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. The Journal of Infectious Diseases. 191: 1093-104. PMID 15747245 DOI: 10.1086/427813 |
0.363 |
|
| 2005 |
Durbin AP, Whitehead SS, McArthur J, Perreault JR, Blaney JE, Thumar B, Murphy BR, Karron RA. rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. The Journal of Infectious Diseases. 191: 710-8. PMID 15688284 DOI: 10.1086/427780 |
0.378 |
|
| 2005 |
Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, Subbarao K. Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters Journal of Virology. 79: 503-511. PMID 15596843 DOI: 10.1128/Jvi.79.1.503-511.2005 |
0.372 |
|
| 2004 |
Blaney JE, Hanson CT, Firestone CY, Hanley KA, Murphy BR, Whitehead SS. Genetically modified, live attenuated dengue virus type 3 vaccine candidates. The American Journal of Tropical Medicine and Hygiene. 71: 811-21. PMID 15642976 DOI: 10.4269/Ajtmh.2004.71.811 |
0.402 |
|
| 2004 |
Lavrador K, Murphy B, Saunders J, Struthers S, Wang X, Williams J. A screening library for peptide activated G-protein coupled receptors. 1. The test set. Journal of Medicinal Chemistry. 47: 6864-74. PMID 15615535 DOI: 10.1021/jm040084c |
0.305 |
|
| 2004 |
Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, et al. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. The Journal of Infectious Diseases. 190: 2096-103. PMID 15551207 DOI: 10.1086/425981 |
0.477 |
|
| 2004 |
McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, Butler E, Zaki S, St Claire M, Murphy B, Subbarao K. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology. 330: 8-15. PMID 15527829 DOI: 10.1016/J.Virol.2004.09.030 |
0.396 |
|
| 2004 |
Blaney JE, Hanson CT, Hanley KA, Murphy BR, Whitehead SS. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2. Bmc Infectious Diseases. 4: 39. PMID 15461822 DOI: 10.1186/1471-2334-4-39 |
0.34 |
|
| 2004 |
Hanley KA, Manlucu LR, Manipon GG, Hanson CT, Whitehead SS, Murphy BR, Blaney JE. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity. Vaccine. 22: 3440-8. PMID 15308370 DOI: 10.1016/J.Vaccine.2004.02.031 |
0.36 |
|
| 2004 |
Murphy BR, Blaney JE, Whitehead SS. Arguments for live flavivirus vaccines. Lancet (London, England). 364: 499-500. PMID 15302187 DOI: 10.1016/S0140-6736(04)16801-3 |
0.329 |
|
| 2004 |
Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 428: 561-4. PMID 15024391 DOI: 10.1038/Nature02463 |
0.305 |
|
| 2004 |
Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinberg GA, ... ... Murphy B, et al. Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. The Journal of Infectious Diseases. 189: 462-70. PMID 14745704 DOI: 10.1086/381184 |
0.432 |
|
| 2003 |
Pletnev AG, Claire MS, Elkins R, Speicher J, Murphy BR, Chanock RM. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology. 314: 190-5. PMID 14517072 DOI: 10.1016/S0042-6822(03)00450-1 |
0.552 |
|
| 2003 |
Whitehead SS, Hanley KA, Blaney JE, Gilmore LE, Elkins WR, Murphy BR. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine. 21: 4307-16. PMID 14505913 DOI: 10.1016/S0264-410X(03)00488-2 |
0.344 |
|
| 2003 |
Karron RA, Belshe RB, Wright PF, Thumar B, Burns B, Newman F, Cannon JC, Thompson J, Tsai T, Paschalis M, Wu SL, Mitcho Y, Hackell J, Murphy BR, Tatem JM. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants. The Pediatric Infectious Disease Journal. 22: 394-405. PMID 12792378 DOI: 10.1097/01.inf.0000066244.31769.83 |
0.334 |
|
| 2003 |
Blaney JE, Manipon GG, Murphy BR, Whitehead SS. Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice. Archives of Virology. 148: 999-1006. PMID 12721805 DOI: 10.1007/S00705-003-0007-Y |
0.381 |
|
| 2003 |
Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. The Journal of Infectious Diseases. 187: 1301-8. PMID 12696010 DOI: 10.1086/367895 |
0.51 |
|
| 2003 |
Whitehead SS, Falgout B, Hanley KA, Blaney Jr JE, Markoff L, Murphy BR. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. Journal of Virology. 77: 1653-7. PMID 12502885 DOI: 10.1128/Jvi.77.2.1653-1657.2003 |
0.368 |
|
| 2003 |
Murphy BR, Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunology. 15: 295-323. PMID 12081014 DOI: 10.1089/08828240260066242 |
0.346 |
|
| 2002 |
Bukreyev A, Skiadopoulos MH, McAuliffe J, Murphy BR, Collins PL, Schmidt AC. More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? Proceedings of the National Academy of Sciences of the United States of America. 99: 16987-16991. PMID 12482928 DOI: 10.1073/Pnas.252649299 |
0.378 |
|
| 2002 |
Murphy BR, Collins PL. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. The Journal of Clinical Investigation. 110: 21-7. PMID 12093883 DOI: 10.1172/JCI16077 |
0.345 |
|
| 2002 |
Collins PL, Murphy BR. Respiratory syncytial virus: reverse genetics and vaccine strategies. Virology. 296: 204-11. PMID 12069519 DOI: 10.1006/VIRO.2002.1437 |
0.348 |
|
| 2002 |
Skiadopoulos MH, Tatem JM, Surman SR, Mitcho Y, Wu SL, Elkins WR, Murphy BR. The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys. Vaccine. 20: 1846-52. PMID 11906774 |
0.374 |
|
| 2002 |
Schmidt AC, Wenzke DR, McAuliffe JM, St Claire M, Elkins WR, Murphy BR, Collins PL. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. Journal of Virology. 76: 1089-99. PMID 11773385 DOI: 10.1128/JVI.76.3.1089-1099.2002 |
0.362 |
|
| 1995 |
Karron RA, Steinhoff MC, Subbarao EK, Wilson MH, Macleod K, Clements ML, Fries LF, Murphy BR. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. The Pediatric Infectious Disease Journal. 14: 10-6. PMID 7715982 DOI: 10.1097/00006454-199501000-00002 |
0.428 |
|
| 1989 |
Treanor J, Yoshihiro K, Miller R, Webster RG, Murphy B. Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes. Virus Research. 14: 257-269. PMID 2483012 DOI: 10.1016/0168-1702(89)90006-3 |
0.354 |
|
| Show low-probability matches. |